nodes	percent_of_prediction	percent_of_DWPC	metapath
Meloxicam—PTGS2—Risedronate—osteoporosis	0.17	0.266	CbGbCtD
Meloxicam—ABCC4—Conjugated Estrogens—osteoporosis	0.103	0.162	CbGbCtD
Meloxicam—CYP2C9—Estropipate—osteoporosis	0.0437	0.0685	CbGbCtD
Meloxicam—CYP2C8—Raloxifene—osteoporosis	0.0418	0.0655	CbGbCtD
Meloxicam—CYP2C8—Ethinyl Estradiol—osteoporosis	0.0404	0.0633	CbGbCtD
Meloxicam—CYP2C8—Cholecalciferol—osteoporosis	0.0323	0.0506	CbGbCtD
Meloxicam—CYP2C8—Estradiol—osteoporosis	0.026	0.0408	CbGbCtD
Meloxicam—CYP3A4—Estropipate—osteoporosis	0.0254	0.0398	CbGbCtD
Meloxicam—CYP3A4—Calcitriol—osteoporosis	0.0254	0.0398	CbGbCtD
Meloxicam—CYP2C9—Cholecalciferol—osteoporosis	0.0225	0.0353	CbGbCtD
Meloxicam—CYP3A4—Ergocalciferol—osteoporosis	0.0203	0.0318	CbGbCtD
Meloxicam—CYP2C9—Estradiol—osteoporosis	0.0182	0.0284	CbGbCtD
Meloxicam—CYP3A4—Raloxifene—osteoporosis	0.017	0.0266	CbGbCtD
Meloxicam—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0164	0.0257	CbGbCtD
Meloxicam—CYP3A4—Cholecalciferol—osteoporosis	0.0131	0.0205	CbGbCtD
Meloxicam—CYP3A4—Conjugated Estrogens—osteoporosis	0.012	0.0188	CbGbCtD
Meloxicam—CYP3A4—Estradiol—osteoporosis	0.0106	0.0165	CbGbCtD
Meloxicam—Erythema multiforme—Estradiol—osteoporosis	0.000161	0.000585	CcSEcCtD
Meloxicam—Hypotension—Pamidronate—osteoporosis	0.00016	0.000584	CcSEcCtD
Meloxicam—Convulsion—Conjugated Estrogens—osteoporosis	0.00016	0.000583	CcSEcCtD
Meloxicam—Dry mouth—Zoledronate—osteoporosis	0.00016	0.000582	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.00016	0.000582	CcSEcCtD
Meloxicam—Fatigue—Ethinyl Estradiol—osteoporosis	0.000159	0.000581	CcSEcCtD
Meloxicam—Pruritus—Alendronate—osteoporosis	0.000159	0.000579	CcSEcCtD
Meloxicam—Dyspepsia—Risedronate—osteoporosis	0.000159	0.000578	CcSEcCtD
Meloxicam—Eye disorder—Estradiol—osteoporosis	0.000159	0.000578	CcSEcCtD
Meloxicam—Tinnitus—Estradiol—osteoporosis	0.000158	0.000577	CcSEcCtD
Meloxicam—Constipation—Ethinyl Estradiol—osteoporosis	0.000158	0.000576	CcSEcCtD
Meloxicam—Confusional state—Zoledronate—osteoporosis	0.000158	0.000575	CcSEcCtD
Meloxicam—Hypersensitivity—Calcitriol—osteoporosis	0.000158	0.000575	CcSEcCtD
Meloxicam—Flushing—Estradiol—osteoporosis	0.000158	0.000574	CcSEcCtD
Meloxicam—Cardiac disorder—Estradiol—osteoporosis	0.000158	0.000574	CcSEcCtD
Meloxicam—Myalgia—Conjugated Estrogens—osteoporosis	0.000157	0.000573	CcSEcCtD
Meloxicam—Arthralgia—Conjugated Estrogens—osteoporosis	0.000157	0.000573	CcSEcCtD
Meloxicam—Asthenia—Ibandronate—osteoporosis	0.000157	0.000572	CcSEcCtD
Meloxicam—Anxiety—Conjugated Estrogens—osteoporosis	0.000157	0.000571	CcSEcCtD
Meloxicam—Nausea—Etidronic acid—osteoporosis	0.000157	0.000571	CcSEcCtD
Meloxicam—Anaphylactic shock—Zoledronate—osteoporosis	0.000157	0.000571	CcSEcCtD
Meloxicam—Oedema—Zoledronate—osteoporosis	0.000157	0.000571	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000156	0.000569	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000156	0.000569	CcSEcCtD
Meloxicam—Diarrhoea—Estropipate—osteoporosis	0.000156	0.000569	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Risedronate—osteoporosis	0.000156	0.000567	CcSEcCtD
Meloxicam—Infection—Zoledronate—osteoporosis	0.000156	0.000567	CcSEcCtD
Meloxicam—Fatigue—Risedronate—osteoporosis	0.000155	0.000566	CcSEcCtD
Meloxicam—Insomnia—Pamidronate—osteoporosis	0.000155	0.000565	CcSEcCtD
Meloxicam—Pruritus—Ibandronate—osteoporosis	0.000155	0.000564	CcSEcCtD
Meloxicam—Constipation—Risedronate—osteoporosis	0.000154	0.000562	CcSEcCtD
Meloxicam—Pain—Risedronate—osteoporosis	0.000154	0.000562	CcSEcCtD
Meloxicam—Angiopathy—Estradiol—osteoporosis	0.000154	0.000561	CcSEcCtD
Meloxicam—Shock—Zoledronate—osteoporosis	0.000154	0.000561	CcSEcCtD
Meloxicam—Paraesthesia—Pamidronate—osteoporosis	0.000154	0.000561	CcSEcCtD
Meloxicam—Diarrhoea—Alendronate—osteoporosis	0.000154	0.00056	CcSEcCtD
Meloxicam—Asthenia—Calcitriol—osteoporosis	0.000154	0.00056	CcSEcCtD
Meloxicam—Nervous system disorder—Zoledronate—osteoporosis	0.000154	0.000559	CcSEcCtD
Meloxicam—Immune system disorder—Estradiol—osteoporosis	0.000153	0.000559	CcSEcCtD
Meloxicam—Thrombocytopenia—Zoledronate—osteoporosis	0.000153	0.000559	CcSEcCtD
Meloxicam—Mediastinal disorder—Estradiol—osteoporosis	0.000153	0.000558	CcSEcCtD
Meloxicam—Dyspnoea—Pamidronate—osteoporosis	0.000153	0.000557	CcSEcCtD
Meloxicam—Tachycardia—Zoledronate—osteoporosis	0.000153	0.000557	CcSEcCtD
Meloxicam—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000152	0.000555	CcSEcCtD
Meloxicam—Somnolence—Pamidronate—osteoporosis	0.000152	0.000555	CcSEcCtD
Meloxicam—Skin disorder—Zoledronate—osteoporosis	0.000152	0.000554	CcSEcCtD
Meloxicam—Pruritus—Calcitriol—osteoporosis	0.000152	0.000552	CcSEcCtD
Meloxicam—Hyperhidrosis—Zoledronate—osteoporosis	0.000151	0.000552	CcSEcCtD
Meloxicam—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000151	0.000551	CcSEcCtD
Meloxicam—Diarrhoea—Raloxifene—osteoporosis	0.000151	0.000551	CcSEcCtD
Meloxicam—Dyspepsia—Pamidronate—osteoporosis	0.000151	0.00055	CcSEcCtD
Meloxicam—Dizziness—Estropipate—osteoporosis	0.000151	0.00055	CcSEcCtD
Meloxicam—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000151	0.000549	CcSEcCtD
Meloxicam—Oedema—Conjugated Estrogens—osteoporosis	0.000151	0.000549	CcSEcCtD
Meloxicam—Alopecia—Estradiol—osteoporosis	0.00015	0.000547	CcSEcCtD
Meloxicam—Infection—Conjugated Estrogens—osteoporosis	0.00015	0.000546	CcSEcCtD
Meloxicam—Diarrhoea—Ibandronate—osteoporosis	0.00015	0.000545	CcSEcCtD
Meloxicam—Decreased appetite—Pamidronate—osteoporosis	0.000149	0.000543	CcSEcCtD
Meloxicam—Mental disorder—Estradiol—osteoporosis	0.000149	0.000542	CcSEcCtD
Meloxicam—Dizziness—Alendronate—osteoporosis	0.000149	0.000541	CcSEcCtD
Meloxicam—Shock—Conjugated Estrogens—osteoporosis	0.000148	0.00054	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000148	0.000539	CcSEcCtD
Meloxicam—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000148	0.000539	CcSEcCtD
Meloxicam—Erythema—Estradiol—osteoporosis	0.000148	0.000539	CcSEcCtD
Meloxicam—Malnutrition—Estradiol—osteoporosis	0.000148	0.000539	CcSEcCtD
Meloxicam—Fatigue—Pamidronate—osteoporosis	0.000148	0.000538	CcSEcCtD
Meloxicam—Gastrointestinal pain—Risedronate—osteoporosis	0.000147	0.000537	CcSEcCtD
Meloxicam—Tachycardia—Conjugated Estrogens—osteoporosis	0.000147	0.000536	CcSEcCtD
Meloxicam—Urticaria—Ethinyl Estradiol—osteoporosis	0.000147	0.000535	CcSEcCtD
Meloxicam—Constipation—Pamidronate—osteoporosis	0.000147	0.000534	CcSEcCtD
Meloxicam—Pain—Pamidronate—osteoporosis	0.000147	0.000534	CcSEcCtD
Meloxicam—Diarrhoea—Calcitriol—osteoporosis	0.000147	0.000534	CcSEcCtD
Meloxicam—Skin disorder—Conjugated Estrogens—osteoporosis	0.000146	0.000534	CcSEcCtD
Meloxicam—Hypotension—Zoledronate—osteoporosis	0.000146	0.000533	CcSEcCtD
Meloxicam—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000146	0.000533	CcSEcCtD
Meloxicam—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000146	0.000533	CcSEcCtD
Meloxicam—Dizziness—Raloxifene—osteoporosis	0.000146	0.000533	CcSEcCtD
Meloxicam—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000146	0.000531	CcSEcCtD
Meloxicam—Flatulence—Estradiol—osteoporosis	0.000146	0.000531	CcSEcCtD
Meloxicam—Tension—Estradiol—osteoporosis	0.000145	0.000529	CcSEcCtD
Meloxicam—Vomiting—Estropipate—osteoporosis	0.000145	0.000529	CcSEcCtD
Meloxicam—Dysgeusia—Estradiol—osteoporosis	0.000145	0.000528	CcSEcCtD
Meloxicam—Dizziness—Ibandronate—osteoporosis	0.000145	0.000527	CcSEcCtD
Meloxicam—Rash—Estropipate—osteoporosis	0.000144	0.000524	CcSEcCtD
Meloxicam—Dermatitis—Estropipate—osteoporosis	0.000144	0.000524	CcSEcCtD
Meloxicam—Nervousness—Estradiol—osteoporosis	0.000144	0.000523	CcSEcCtD
Meloxicam—Urticaria—Risedronate—osteoporosis	0.000143	0.000522	CcSEcCtD
Meloxicam—Back pain—Estradiol—osteoporosis	0.000143	0.000521	CcSEcCtD
Meloxicam—Headache—Estropipate—osteoporosis	0.000143	0.000521	CcSEcCtD
Meloxicam—Vomiting—Alendronate—osteoporosis	0.000143	0.000521	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000143	0.00052	CcSEcCtD
Meloxicam—Abdominal pain—Risedronate—osteoporosis	0.000143	0.000519	CcSEcCtD
Meloxicam—Body temperature increased—Risedronate—osteoporosis	0.000143	0.000519	CcSEcCtD
Meloxicam—Muscle spasms—Estradiol—osteoporosis	0.000142	0.000518	CcSEcCtD
Meloxicam—Rash—Alendronate—osteoporosis	0.000142	0.000516	CcSEcCtD
Meloxicam—Insomnia—Zoledronate—osteoporosis	0.000142	0.000516	CcSEcCtD
Meloxicam—Dermatitis—Alendronate—osteoporosis	0.000142	0.000516	CcSEcCtD
Meloxicam—Feeling abnormal—Pamidronate—osteoporosis	0.000141	0.000515	CcSEcCtD
Meloxicam—Hypotension—Conjugated Estrogens—osteoporosis	0.000141	0.000513	CcSEcCtD
Meloxicam—Headache—Alendronate—osteoporosis	0.000141	0.000513	CcSEcCtD
Meloxicam—Paraesthesia—Zoledronate—osteoporosis	0.000141	0.000512	CcSEcCtD
Meloxicam—Vomiting—Raloxifene—osteoporosis	0.000141	0.000512	CcSEcCtD
Meloxicam—Gastrointestinal pain—Pamidronate—osteoporosis	0.00014	0.000511	CcSEcCtD
Meloxicam—Dyspnoea—Zoledronate—osteoporosis	0.00014	0.000509	CcSEcCtD
Meloxicam—Rash—Raloxifene—osteoporosis	0.000139	0.000508	CcSEcCtD
Meloxicam—Dermatitis—Raloxifene—osteoporosis	0.000139	0.000507	CcSEcCtD
Meloxicam—Somnolence—Zoledronate—osteoporosis	0.000139	0.000507	CcSEcCtD
Meloxicam—Vomiting—Ibandronate—osteoporosis	0.000139	0.000507	CcSEcCtD
Meloxicam—Tremor—Estradiol—osteoporosis	0.000139	0.000505	CcSEcCtD
Meloxicam—Headache—Raloxifene—osteoporosis	0.000138	0.000505	CcSEcCtD
Meloxicam—Rash—Ibandronate—osteoporosis	0.000138	0.000503	CcSEcCtD
Meloxicam—Dermatitis—Ibandronate—osteoporosis	0.000138	0.000502	CcSEcCtD
Meloxicam—Dyspepsia—Zoledronate—osteoporosis	0.000138	0.000502	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000137	0.0005	CcSEcCtD
Meloxicam—Ill-defined disorder—Estradiol—osteoporosis	0.000137	0.0005	CcSEcCtD
Meloxicam—Headache—Ibandronate—osteoporosis	0.000137	0.000499	CcSEcCtD
Meloxicam—Insomnia—Conjugated Estrogens—osteoporosis	0.000136	0.000497	CcSEcCtD
Meloxicam—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000136	0.000496	CcSEcCtD
Meloxicam—Vomiting—Calcitriol—osteoporosis	0.000136	0.000496	CcSEcCtD
Meloxicam—Decreased appetite—Zoledronate—osteoporosis	0.000136	0.000496	CcSEcCtD
Meloxicam—Nausea—Estropipate—osteoporosis	0.000136	0.000494	CcSEcCtD
Meloxicam—Body temperature increased—Pamidronate—osteoporosis	0.000135	0.000494	CcSEcCtD
Meloxicam—Abdominal pain—Pamidronate—osteoporosis	0.000135	0.000494	CcSEcCtD
Meloxicam—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000135	0.000493	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000135	0.000493	CcSEcCtD
Meloxicam—Angioedema—Estradiol—osteoporosis	0.000135	0.000492	CcSEcCtD
Meloxicam—Rash—Calcitriol—osteoporosis	0.000135	0.000492	CcSEcCtD
Meloxicam—Fatigue—Zoledronate—osteoporosis	0.000135	0.000492	CcSEcCtD
Meloxicam—Dermatitis—Calcitriol—osteoporosis	0.000135	0.000492	CcSEcCtD
Meloxicam—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000134	0.00049	CcSEcCtD
Meloxicam—Headache—Calcitriol—osteoporosis	0.000134	0.000489	CcSEcCtD
Meloxicam—Somnolence—Conjugated Estrogens—osteoporosis	0.000134	0.000488	CcSEcCtD
Meloxicam—Constipation—Zoledronate—osteoporosis	0.000134	0.000488	CcSEcCtD
Meloxicam—Pain—Zoledronate—osteoporosis	0.000134	0.000488	CcSEcCtD
Meloxicam—Nausea—Alendronate—osteoporosis	0.000133	0.000486	CcSEcCtD
Meloxicam—Malaise—Estradiol—osteoporosis	0.000133	0.000486	CcSEcCtD
Meloxicam—Hypersensitivity—Risedronate—osteoporosis	0.000133	0.000484	CcSEcCtD
Meloxicam—Vertigo—Estradiol—osteoporosis	0.000133	0.000484	CcSEcCtD
Meloxicam—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000133	0.000484	CcSEcCtD
Meloxicam—Asthenia—Ethinyl Estradiol—osteoporosis	0.000133	0.000483	CcSEcCtD
Meloxicam—Syncope—Estradiol—osteoporosis	0.000133	0.000483	CcSEcCtD
Meloxicam—Nausea—Raloxifene—osteoporosis	0.000131	0.000478	CcSEcCtD
Meloxicam—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000131	0.000478	CcSEcCtD
Meloxicam—Pruritus—Ethinyl Estradiol—osteoporosis	0.000131	0.000477	CcSEcCtD
Meloxicam—Palpitations—Estradiol—osteoporosis	0.000131	0.000476	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.00013	0.000474	CcSEcCtD
Meloxicam—Fatigue—Conjugated Estrogens—osteoporosis	0.00013	0.000474	CcSEcCtD
Meloxicam—Nausea—Ibandronate—osteoporosis	0.00013	0.000474	CcSEcCtD
Meloxicam—Loss of consciousness—Estradiol—osteoporosis	0.00013	0.000473	CcSEcCtD
Meloxicam—Asthenia—Risedronate—osteoporosis	0.000129	0.000471	CcSEcCtD
Meloxicam—Feeling abnormal—Zoledronate—osteoporosis	0.000129	0.00047	CcSEcCtD
Meloxicam—Cough—Estradiol—osteoporosis	0.000129	0.00047	CcSEcCtD
Meloxicam—Pain—Conjugated Estrogens—osteoporosis	0.000129	0.00047	CcSEcCtD
Meloxicam—Constipation—Conjugated Estrogens—osteoporosis	0.000129	0.00047	CcSEcCtD
Meloxicam—Gastrointestinal pain—Zoledronate—osteoporosis	0.000128	0.000467	CcSEcCtD
Meloxicam—Hypertension—Estradiol—osteoporosis	0.000128	0.000465	CcSEcCtD
Meloxicam—Pruritus—Risedronate—osteoporosis	0.000128	0.000465	CcSEcCtD
Meloxicam—Nausea—Calcitriol—osteoporosis	0.000127	0.000464	CcSEcCtD
Meloxicam—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000127	0.000461	CcSEcCtD
Meloxicam—Hypersensitivity—Pamidronate—osteoporosis	0.000126	0.00046	CcSEcCtD
Meloxicam—Arthralgia—Estradiol—osteoporosis	0.000126	0.000459	CcSEcCtD
Meloxicam—Myalgia—Estradiol—osteoporosis	0.000126	0.000459	CcSEcCtD
Meloxicam—Anxiety—Estradiol—osteoporosis	0.000125	0.000457	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000125	0.000455	CcSEcCtD
Meloxicam—Urticaria—Zoledronate—osteoporosis	0.000124	0.000453	CcSEcCtD
Meloxicam—Discomfort—Estradiol—osteoporosis	0.000124	0.000453	CcSEcCtD
Meloxicam—Body temperature increased—Zoledronate—osteoporosis	0.000124	0.000451	CcSEcCtD
Meloxicam—Abdominal pain—Zoledronate—osteoporosis	0.000124	0.000451	CcSEcCtD
Meloxicam—Diarrhoea—Risedronate—osteoporosis	0.000123	0.00045	CcSEcCtD
Meloxicam—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000123	0.000449	CcSEcCtD
Meloxicam—Dry mouth—Estradiol—osteoporosis	0.000123	0.000449	CcSEcCtD
Meloxicam—Asthenia—Pamidronate—osteoporosis	0.000123	0.000448	CcSEcCtD
Meloxicam—Dizziness—Ethinyl Estradiol—osteoporosis	0.000122	0.000446	CcSEcCtD
Meloxicam—Confusional state—Estradiol—osteoporosis	0.000122	0.000443	CcSEcCtD
Meloxicam—Pruritus—Pamidronate—osteoporosis	0.000121	0.000442	CcSEcCtD
Meloxicam—Anaphylactic shock—Estradiol—osteoporosis	0.000121	0.00044	CcSEcCtD
Meloxicam—Oedema—Estradiol—osteoporosis	0.000121	0.00044	CcSEcCtD
Meloxicam—Infection—Estradiol—osteoporosis	0.00012	0.000437	CcSEcCtD
Meloxicam—Urticaria—Conjugated Estrogens—osteoporosis	0.00012	0.000436	CcSEcCtD
Meloxicam—Dizziness—Risedronate—osteoporosis	0.000119	0.000434	CcSEcCtD
Meloxicam—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000119	0.000434	CcSEcCtD
Meloxicam—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000119	0.000434	CcSEcCtD
Meloxicam—Shock—Estradiol—osteoporosis	0.000119	0.000433	CcSEcCtD
Meloxicam—Nervous system disorder—Estradiol—osteoporosis	0.000118	0.000431	CcSEcCtD
Meloxicam—Tachycardia—Estradiol—osteoporosis	0.000118	0.000429	CcSEcCtD
Meloxicam—Vomiting—Ethinyl Estradiol—osteoporosis	0.000118	0.000428	CcSEcCtD
Meloxicam—Diarrhoea—Pamidronate—osteoporosis	0.000117	0.000427	CcSEcCtD
Meloxicam—Skin disorder—Estradiol—osteoporosis	0.000117	0.000427	CcSEcCtD
Meloxicam—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoporosis	0.000117	0.00134	CbGpPWpGaD
Meloxicam—Hyperhidrosis—Estradiol—osteoporosis	0.000117	0.000425	CcSEcCtD
Meloxicam—Rash—Ethinyl Estradiol—osteoporosis	0.000117	0.000425	CcSEcCtD
Meloxicam—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000116	0.000424	CcSEcCtD
Meloxicam—Headache—Ethinyl Estradiol—osteoporosis	0.000116	0.000422	CcSEcCtD
Meloxicam—Hypersensitivity—Zoledronate—osteoporosis	0.000115	0.00042	CcSEcCtD
Meloxicam—Vomiting—Risedronate—osteoporosis	0.000115	0.000418	CcSEcCtD
Meloxicam—ABCC4—Hemostasis—FGA—osteoporosis	0.000114	0.0013	CbGpPWpGaD
Meloxicam—Rash—Risedronate—osteoporosis	0.000114	0.000414	CcSEcCtD
Meloxicam—Dermatitis—Risedronate—osteoporosis	0.000114	0.000414	CcSEcCtD
Meloxicam—Dizziness—Pamidronate—osteoporosis	0.000113	0.000413	CcSEcCtD
Meloxicam—PGD—Disease—CALCA—osteoporosis	0.000113	0.0013	CbGpPWpGaD
Meloxicam—Headache—Risedronate—osteoporosis	0.000113	0.000412	CcSEcCtD
Meloxicam—Asthenia—Zoledronate—osteoporosis	0.000112	0.000409	CcSEcCtD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000111	0.00127	CbGpPWpGaD
Meloxicam—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000111	0.000405	CcSEcCtD
Meloxicam—Pruritus—Zoledronate—osteoporosis	0.000111	0.000404	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Estradiol—osteoporosis	0.00011	0.000401	CcSEcCtD
Meloxicam—Nausea—Ethinyl Estradiol—osteoporosis	0.00011	0.0004	CcSEcCtD
Meloxicam—Insomnia—Estradiol—osteoporosis	0.000109	0.000398	CcSEcCtD
Meloxicam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000109	0.00125	CbGpPWpGaD
Meloxicam—Vomiting—Pamidronate—osteoporosis	0.000109	0.000397	CcSEcCtD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	0.000109	0.00125	CbGpPWpGaD
Meloxicam—Paraesthesia—Estradiol—osteoporosis	0.000108	0.000395	CcSEcCtD
Meloxicam—Asthenia—Conjugated Estrogens—osteoporosis	0.000108	0.000394	CcSEcCtD
Meloxicam—Rash—Pamidronate—osteoporosis	0.000108	0.000394	CcSEcCtD
Meloxicam—Dermatitis—Pamidronate—osteoporosis	0.000108	0.000393	CcSEcCtD
Meloxicam—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000108	0.00123	CbGpPWpGaD
Meloxicam—Dyspnoea—Estradiol—osteoporosis	0.000108	0.000392	CcSEcCtD
Meloxicam—Headache—Pamidronate—osteoporosis	0.000107	0.000391	CcSEcCtD
Meloxicam—PTGS2—Aryl Hydrocarbon Receptor—MYC—osteoporosis	0.000107	0.00123	CbGpPWpGaD
Meloxicam—Somnolence—Estradiol—osteoporosis	0.000107	0.000391	CcSEcCtD
Meloxicam—Diarrhoea—Zoledronate—osteoporosis	0.000107	0.00039	CcSEcCtD
Meloxicam—Nausea—Risedronate—osteoporosis	0.000107	0.00039	CcSEcCtD
Meloxicam—Pruritus—Conjugated Estrogens—osteoporosis	0.000107	0.000389	CcSEcCtD
Meloxicam—Dyspepsia—Estradiol—osteoporosis	0.000106	0.000387	CcSEcCtD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000106	0.00121	CbGpPWpGaD
Meloxicam—Decreased appetite—Estradiol—osteoporosis	0.000105	0.000382	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Estradiol—osteoporosis	0.000104	0.00038	CcSEcCtD
Meloxicam—Fatigue—Estradiol—osteoporosis	0.000104	0.000379	CcSEcCtD
Meloxicam—Dizziness—Zoledronate—osteoporosis	0.000104	0.000377	CcSEcCtD
Meloxicam—ABCC4—Hemostasis—FGB—osteoporosis	0.000104	0.00119	CbGpPWpGaD
Meloxicam—PGD—Metabolism—ENO1—osteoporosis	0.000103	0.00118	CbGpPWpGaD
Meloxicam—PTGS1—Selenium Micronutrient Network—IL1B—osteoporosis	0.000103	0.00118	CbGpPWpGaD
Meloxicam—Constipation—Estradiol—osteoporosis	0.000103	0.000376	CcSEcCtD
Meloxicam—Pain—Estradiol—osteoporosis	0.000103	0.000376	CcSEcCtD
Meloxicam—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000103	0.000376	CcSEcCtD
Meloxicam—PGD—Disease—KL—osteoporosis	0.000103	0.00118	CbGpPWpGaD
Meloxicam—Nausea—Pamidronate—osteoporosis	0.000102	0.000371	CcSEcCtD
Meloxicam—PGD—Metabolism—PSMA2—osteoporosis	0.000102	0.00117	CbGpPWpGaD
Meloxicam—PGD—Metabolism—PSMA5—osteoporosis	0.000102	0.00117	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—LEP—osteoporosis	0.000102	0.00116	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000101	0.00115	CbGpPWpGaD
Meloxicam—PTGS2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	9.99e-05	0.00114	CbGpPWpGaD
Meloxicam—Dizziness—Conjugated Estrogens—osteoporosis	9.97e-05	0.000363	CcSEcCtD
Meloxicam—Vomiting—Zoledronate—osteoporosis	9.95e-05	0.000363	CcSEcCtD
Meloxicam—Feeling abnormal—Estradiol—osteoporosis	9.94e-05	0.000362	CcSEcCtD
Meloxicam—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	9.94e-05	0.00114	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	9.9e-05	0.00113	CbGpPWpGaD
Meloxicam—CYP2C8—Phase 1 - Functionalization of compounds—POMC—osteoporosis	9.9e-05	0.00113	CbGpPWpGaD
Meloxicam—Rash—Zoledronate—osteoporosis	9.87e-05	0.00036	CcSEcCtD
Meloxicam—Gastrointestinal pain—Estradiol—osteoporosis	9.87e-05	0.00036	CcSEcCtD
Meloxicam—Dermatitis—Zoledronate—osteoporosis	9.86e-05	0.000359	CcSEcCtD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	9.83e-05	0.00113	CbGpPWpGaD
Meloxicam—Headache—Zoledronate—osteoporosis	9.81e-05	0.000357	CcSEcCtD
Meloxicam—Vomiting—Conjugated Estrogens—osteoporosis	9.59e-05	0.000349	CcSEcCtD
Meloxicam—Urticaria—Estradiol—osteoporosis	9.59e-05	0.000349	CcSEcCtD
Meloxicam—Abdominal pain—Estradiol—osteoporosis	9.54e-05	0.000348	CcSEcCtD
Meloxicam—Body temperature increased—Estradiol—osteoporosis	9.54e-05	0.000348	CcSEcCtD
Meloxicam—Rash—Conjugated Estrogens—osteoporosis	9.51e-05	0.000346	CcSEcCtD
Meloxicam—Dermatitis—Conjugated Estrogens—osteoporosis	9.5e-05	0.000346	CcSEcCtD
Meloxicam—Headache—Conjugated Estrogens—osteoporosis	9.44e-05	0.000344	CcSEcCtD
Meloxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—osteoporosis	9.35e-05	0.00107	CbGpPWpGaD
Meloxicam—Nausea—Zoledronate—osteoporosis	9.3e-05	0.000339	CcSEcCtD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—IGF1—osteoporosis	9.09e-05	0.00104	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	9.06e-05	0.00104	CbGpPWpGaD
Meloxicam—Nausea—Conjugated Estrogens—osteoporosis	8.95e-05	0.000326	CcSEcCtD
Meloxicam—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	8.94e-05	0.00102	CbGpPWpGaD
Meloxicam—Hypersensitivity—Estradiol—osteoporosis	8.89e-05	0.000324	CcSEcCtD
Meloxicam—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	8.84e-05	0.00101	CbGpPWpGaD
Meloxicam—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	8.82e-05	0.00101	CbGpPWpGaD
Meloxicam—CYP2C8—Biological oxidations—CYP19A1—osteoporosis	8.75e-05	0.001	CbGpPWpGaD
Meloxicam—Asthenia—Estradiol—osteoporosis	8.66e-05	0.000315	CcSEcCtD
Meloxicam—CYP2C8—Metapathway biotransformation—CYP19A1—osteoporosis	8.63e-05	0.000988	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	8.59e-05	0.000983	CbGpPWpGaD
Meloxicam—Pruritus—Estradiol—osteoporosis	8.54e-05	0.000311	CcSEcCtD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	8.42e-05	0.000964	CbGpPWpGaD
Meloxicam—PGD—Metabolism—CYP19A1—osteoporosis	8.26e-05	0.000945	CbGpPWpGaD
Meloxicam—Diarrhoea—Estradiol—osteoporosis	8.26e-05	0.000301	CcSEcCtD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	8.21e-05	0.00094	CbGpPWpGaD
Meloxicam—PTGS2—Selenium Micronutrient Network—IL1B—osteoporosis	8.2e-05	0.000938	CbGpPWpGaD
Meloxicam—PTGS1—Biological oxidations—POMC—osteoporosis	8.14e-05	0.000932	CbGpPWpGaD
Meloxicam—PGD—Disease—ADCY5—osteoporosis	8.06e-05	0.000922	CbGpPWpGaD
Meloxicam—CYP2C9—Phase 1 - Functionalization of compounds—POMC—osteoporosis	8.05e-05	0.000922	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	8e-05	0.000916	CbGpPWpGaD
Meloxicam—Dizziness—Estradiol—osteoporosis	7.98e-05	0.000291	CcSEcCtD
Meloxicam—ABCC4—Ectoderm Differentiation—MYC—osteoporosis	7.96e-05	0.000912	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	7.86e-05	0.0009	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PKM—osteoporosis	7.68e-05	0.000879	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—FDPS—osteoporosis	7.68e-05	0.000879	CbGpPWpGaD
Meloxicam—Vomiting—Estradiol—osteoporosis	7.67e-05	0.00028	CcSEcCtD
Meloxicam—Rash—Estradiol—osteoporosis	7.61e-05	0.000277	CcSEcCtD
Meloxicam—Dermatitis—Estradiol—osteoporosis	7.6e-05	0.000277	CcSEcCtD
Meloxicam—ABCC4—NRF2 pathway—TGFB1—osteoporosis	7.59e-05	0.000869	CbGpPWpGaD
Meloxicam—Headache—Estradiol—osteoporosis	7.56e-05	0.000275	CcSEcCtD
Meloxicam—PTGS1—Selenium Micronutrient Network—TNF—osteoporosis	7.49e-05	0.000858	CbGpPWpGaD
Meloxicam—PGD—Disease—MTHFR—osteoporosis	7.41e-05	0.000848	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PGLS—osteoporosis	7.28e-05	0.000833	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—GPD2—osteoporosis	7.28e-05	0.000833	CbGpPWpGaD
Meloxicam—PTGS2—Disease—SOST—osteoporosis	7.28e-05	0.000833	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PKM—osteoporosis	7.28e-05	0.000833	CbGpPWpGaD
Meloxicam—Nausea—Estradiol—osteoporosis	7.17e-05	0.000261	CcSEcCtD
Meloxicam—CYP2C9—Biological oxidations—CYP19A1—osteoporosis	7.12e-05	0.000815	CbGpPWpGaD
Meloxicam—PGD—Disease—IRS2—osteoporosis	7.05e-05	0.000807	CbGpPWpGaD
Meloxicam—CYP2C9—Metapathway biotransformation—CYP19A1—osteoporosis	7.02e-05	0.000804	CbGpPWpGaD
Meloxicam—PTGS2—Disease—ANTXR2—osteoporosis	6.9e-05	0.00079	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PGLS—osteoporosis	6.9e-05	0.00079	CbGpPWpGaD
Meloxicam—PGD—Metabolism—ADCY5—osteoporosis	6.75e-05	0.000772	CbGpPWpGaD
Meloxicam—PGD—Metabolism—GPX1—osteoporosis	6.72e-05	0.00077	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	6.68e-05	0.000765	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	6.68e-05	0.000765	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ATIC—osteoporosis	6.66e-05	0.000762	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PNP—osteoporosis	6.66e-05	0.000762	CbGpPWpGaD
Meloxicam—PTGS2—C-MYB transcription factor network—MYC—osteoporosis	6.63e-05	0.000759	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	6.6e-05	0.000756	CbGpPWpGaD
Meloxicam—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	6.55e-05	0.00075	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	6.51e-05	0.000745	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—IL1B—osteoporosis	6.48e-05	0.000742	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	6.39e-05	0.000732	CbGpPWpGaD
Meloxicam—PGD—Metabolism—MTHFR—osteoporosis	6.2e-05	0.00071	CbGpPWpGaD
Meloxicam—PGD—Disease—IRS1—osteoporosis	6.15e-05	0.000704	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PKM—osteoporosis	6.09e-05	0.000698	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—FDPS—osteoporosis	6.09e-05	0.000698	CbGpPWpGaD
Meloxicam—PTGS1—Selenium Micronutrient Network—IL6—osteoporosis	6.05e-05	0.000692	CbGpPWpGaD
Meloxicam—PTGS2—Selenium Micronutrient Network—TNF—osteoporosis	5.95e-05	0.000681	CbGpPWpGaD
Meloxicam—PTGS2—Disease—GSN—osteoporosis	5.87e-05	0.000671	CbGpPWpGaD
Meloxicam—PGD—Disease—IL6R—osteoporosis	5.78e-05	0.000662	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—GPD2—osteoporosis	5.78e-05	0.000661	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PGLS—osteoporosis	5.78e-05	0.000661	CbGpPWpGaD
Meloxicam—ABCC4—Transmembrane transport of small molecules—ADCY5—osteoporosis	5.73e-05	0.000656	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	5.72e-05	0.000654	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CA2—osteoporosis	5.66e-05	0.000648	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—OXCT1—osteoporosis	5.66e-05	0.000648	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—MGLL—osteoporosis	5.51e-05	0.000631	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	5.45e-05	0.000624	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	5.44e-05	0.000622	CbGpPWpGaD
Meloxicam—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	5.31e-05	0.000608	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ATIC—osteoporosis	5.28e-05	0.000605	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PNP—osteoporosis	5.28e-05	0.000605	CbGpPWpGaD
Meloxicam—CYP2C8—Biological oxidations—POMC—osteoporosis	5.26e-05	0.000602	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	5.2e-05	0.000596	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	5.2e-05	0.000595	CbGpPWpGaD
Meloxicam—PTGS2—Disease—LRP5—osteoporosis	5.1e-05	0.000584	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—MYC—osteoporosis	5.05e-05	0.000578	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—TGFB1—osteoporosis	5.04e-05	0.000577	CbGpPWpGaD
Meloxicam—PGD—Metabolism—POMC—osteoporosis	4.96e-05	0.000568	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PKM—osteoporosis	4.96e-05	0.000568	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—FDPS—osteoporosis	4.96e-05	0.000568	CbGpPWpGaD
Meloxicam—PTGS2—Disease—LRP6—osteoporosis	4.88e-05	0.000559	CbGpPWpGaD
Meloxicam—PTGS2—Selenium Micronutrient Network—IL6—osteoporosis	4.8e-05	0.000549	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—TNF—osteoporosis	4.7e-05	0.000538	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GPD2—osteoporosis	4.7e-05	0.000538	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PGLS—osteoporosis	4.7e-05	0.000538	CbGpPWpGaD
Meloxicam—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	4.7e-05	0.000537	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—IDH2—osteoporosis	4.69e-05	0.000537	CbGpPWpGaD
Meloxicam—PTGS2—Disease—LTF—osteoporosis	4.69e-05	0.000537	CbGpPWpGaD
Meloxicam—PTGS2—Disease—RPL24—osteoporosis	4.69e-05	0.000537	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—IGF1—osteoporosis	4.69e-05	0.000537	CbGpPWpGaD
Meloxicam—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	4.63e-05	0.00053	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CA2—osteoporosis	4.49e-05	0.000514	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—OXCT1—osteoporosis	4.49e-05	0.000514	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	4.43e-05	0.000507	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CYP27A1—osteoporosis	4.41e-05	0.000505	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—MGLL—osteoporosis	4.38e-05	0.000501	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ATIC—osteoporosis	4.3e-05	0.000492	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PNP—osteoporosis	4.3e-05	0.000492	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ACP5—osteoporosis	4.29e-05	0.000491	CbGpPWpGaD
Meloxicam—CYP2C9—Biological oxidations—POMC—osteoporosis	4.28e-05	0.00049	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	4.23e-05	0.000485	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	4.13e-05	0.000473	CbGpPWpGaD
Meloxicam—PTGS2—Disease—ACP5—osteoporosis	4.07e-05	0.000465	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—FDPS—osteoporosis	4.04e-05	0.000462	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PKM—osteoporosis	4.04e-05	0.000462	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—TPI1—osteoporosis	3.99e-05	0.000456	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PGLS—osteoporosis	3.83e-05	0.000438	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GPD2—osteoporosis	3.83e-05	0.000438	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—IL6—osteoporosis	3.8e-05	0.000434	CbGpPWpGaD
Meloxicam—PTGS2—Disease—TPI1—osteoporosis	3.78e-05	0.000433	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—P4HB—osteoporosis	3.75e-05	0.000429	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—IDH2—osteoporosis	3.72e-05	0.000426	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—GAPDH—osteoporosis	3.68e-05	0.000421	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—OXCT1—osteoporosis	3.66e-05	0.000418	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CA2—osteoporosis	3.66e-05	0.000418	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—RAP1A—osteoporosis	3.58e-05	0.00041	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—MGLL—osteoporosis	3.56e-05	0.000408	CbGpPWpGaD
Meloxicam—PTGS2—Disease—P4HB—osteoporosis	3.55e-05	0.000407	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CYP27A1—osteoporosis	3.5e-05	0.000401	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PNP—osteoporosis	3.5e-05	0.000401	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ATIC—osteoporosis	3.5e-05	0.000401	CbGpPWpGaD
Meloxicam—PTGS2—Disease—GAPDH—osteoporosis	3.49e-05	0.000399	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	3.43e-05	0.000393	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	3.43e-05	0.000392	CbGpPWpGaD
Meloxicam—PGD—Disease—MYC—osteoporosis	3.43e-05	0.000392	CbGpPWpGaD
Meloxicam—PGD—Disease—TGFB1—osteoporosis	3.42e-05	0.000391	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ACP5—osteoporosis	3.4e-05	0.00039	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3.36e-05	0.000385	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	3.36e-05	0.000385	CbGpPWpGaD
Meloxicam—PTGS2—Disease—NFATC1—osteoporosis	3.31e-05	0.000379	CbGpPWpGaD
Meloxicam—PTGS2—Disease—DKK1—osteoporosis	3.29e-05	0.000376	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	3.2e-05	0.000366	CbGpPWpGaD
Meloxicam—PTGS2—Disease—WNT1—osteoporosis	3.17e-05	0.000363	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—TPI1—osteoporosis	3.17e-05	0.000362	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.13e-05	0.000358	CbGpPWpGaD
Meloxicam—PTGS2—Disease—FGA—osteoporosis	3.08e-05	0.000353	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—IDH2—osteoporosis	3.03e-05	0.000347	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—P4HB—osteoporosis	2.98e-05	0.000341	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CA2—osteoporosis	2.97e-05	0.000341	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—OXCT1—osteoporosis	2.97e-05	0.000341	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—GAPDH—osteoporosis	2.92e-05	0.000334	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—MGLL—osteoporosis	2.9e-05	0.000332	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ENO1—osteoporosis	2.9e-05	0.000332	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PSMA5—osteoporosis	2.85e-05	0.000327	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PSMA2—osteoporosis	2.85e-05	0.000327	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CYP27A1—osteoporosis	2.85e-05	0.000326	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—RAP1A—osteoporosis	2.84e-05	0.000326	CbGpPWpGaD
Meloxicam—CYP3A4—Biological oxidations—POMC—osteoporosis	2.82e-05	0.000323	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—TGFB1—osteoporosis	2.81e-05	0.000322	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ACP5—osteoporosis	2.77e-05	0.000317	CbGpPWpGaD
Meloxicam—PTGS2—Disease—ENO1—osteoporosis	2.75e-05	0.000314	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.74e-05	0.000313	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.73e-05	0.000313	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PSMA2—osteoporosis	2.71e-05	0.00031	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PSMA5—osteoporosis	2.71e-05	0.00031	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PKM—osteoporosis	2.66e-05	0.000305	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—FDPS—osteoporosis	2.66e-05	0.000305	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—TPI1—osteoporosis	2.58e-05	0.000295	CbGpPWpGaD
Meloxicam—PGD—Disease—IL6—osteoporosis	2.57e-05	0.000295	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PGLS—osteoporosis	2.52e-05	0.000289	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GPD2—osteoporosis	2.52e-05	0.000289	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CALCA—osteoporosis	2.52e-05	0.000289	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.48e-05	0.000284	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—IDH2—osteoporosis	2.47e-05	0.000282	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—P4HB—osteoporosis	2.42e-05	0.000277	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GAPDH—osteoporosis	2.38e-05	0.000272	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CYP27A1—osteoporosis	2.32e-05	0.000265	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CYP19A1—osteoporosis	2.32e-05	0.000265	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—RAP1A—osteoporosis	2.31e-05	0.000265	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ATIC—osteoporosis	2.31e-05	0.000264	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PNP—osteoporosis	2.31e-05	0.000264	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ENO1—osteoporosis	2.3e-05	0.000263	CbGpPWpGaD
Meloxicam—PTGS2—Disease—KL—osteoporosis	2.29e-05	0.000262	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PSMA5—osteoporosis	2.27e-05	0.000259	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PSMA2—osteoporosis	2.27e-05	0.000259	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ACP5—osteoporosis	2.25e-05	0.000258	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.23e-05	0.000255	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—TPI1—osteoporosis	2.1e-05	0.00024	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.02e-05	0.000231	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—P4HB—osteoporosis	1.97e-05	0.000226	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—OXCT1—osteoporosis	1.96e-05	0.000225	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CA2—osteoporosis	1.96e-05	0.000225	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GAPDH—osteoporosis	1.93e-05	0.000221	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—MGLL—osteoporosis	1.91e-05	0.000219	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ADCY5—osteoporosis	1.89e-05	0.000217	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—GPX1—osteoporosis	1.89e-05	0.000216	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—RAP1A—osteoporosis	1.88e-05	0.000216	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ENO1—osteoporosis	1.87e-05	0.000214	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PSMA2—osteoporosis	1.84e-05	0.000211	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PSMA5—osteoporosis	1.84e-05	0.000211	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CYP19A1—osteoporosis	1.84e-05	0.00021	CbGpPWpGaD
Meloxicam—PTGS2—Disease—ADCY5—osteoporosis	1.79e-05	0.000205	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—MTHFR—osteoporosis	1.74e-05	0.000199	CbGpPWpGaD
Meloxicam—PTGS2—Disease—MTHFR—osteoporosis	1.65e-05	0.000189	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.64e-05	0.000188	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—IDH2—osteoporosis	1.63e-05	0.000186	CbGpPWpGaD
Meloxicam—PTGS2—Disease—IRS2—osteoporosis	1.57e-05	0.00018	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.53e-05	0.000175	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ENO1—osteoporosis	1.52e-05	0.000174	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ADCY5—osteoporosis	1.5e-05	0.000172	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PSMA5—osteoporosis	1.5e-05	0.000172	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PSMA2—osteoporosis	1.5e-05	0.000172	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—GPX1—osteoporosis	1.5e-05	0.000171	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CYP19A1—osteoporosis	1.5e-05	0.000171	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ACP5—osteoporosis	1.49e-05	0.00017	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—POMC—osteoporosis	1.39e-05	0.000159	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—TPI1—osteoporosis	1.38e-05	0.000158	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—MTHFR—osteoporosis	1.38e-05	0.000158	CbGpPWpGaD
Meloxicam—PTGS2—Disease—IRS1—osteoporosis	1.37e-05	0.000157	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—P4HB—osteoporosis	1.3e-05	0.000149	CbGpPWpGaD
Meloxicam—PTGS2—Disease—IL6R—osteoporosis	1.29e-05	0.000147	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GAPDH—osteoporosis	1.28e-05	0.000146	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—RAP1A—osteoporosis	1.24e-05	0.000142	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ADCY5—osteoporosis	1.22e-05	0.00014	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GPX1—osteoporosis	1.22e-05	0.000139	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CYP19A1—osteoporosis	1.22e-05	0.000139	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—MTHFR—osteoporosis	1.12e-05	0.000129	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—POMC—osteoporosis	1.1e-05	0.000126	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ENO1—osteoporosis	1e-05	0.000115	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ADCY5—osteoporosis	9.95e-06	0.000114	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GPX1—osteoporosis	9.91e-06	0.000113	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PSMA2—osteoporosis	9.9e-06	0.000113	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PSMA5—osteoporosis	9.9e-06	0.000113	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—MTHFR—osteoporosis	9.15e-06	0.000105	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—POMC—osteoporosis	8.99e-06	0.000103	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CYP19A1—osteoporosis	8.03e-06	9.19e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—MYC—osteoporosis	7.63e-06	8.73e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—TGFB1—osteoporosis	7.61e-06	8.71e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—POMC—osteoporosis	7.32e-06	8.38e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ADCY5—osteoporosis	6.56e-06	7.51e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GPX1—osteoporosis	6.54e-06	7.48e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—MTHFR—osteoporosis	6.03e-06	6.91e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—IL6—osteoporosis	5.73e-06	6.56e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—POMC—osteoporosis	4.83e-06	5.52e-05	CbGpPWpGaD
